Skip to Main Content

Paper Details

Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors.
Neurooncol Adv
1
2022
CNS tumors, INDELs, RNA, SNVs, central nervous system tumors, methylation, patients, pediatric, pediatric CNS tumors, pediatric central nervous system (CNS) tumors, pediatric tumors, tier 1 or tier 2 variants, tumor
Author NameAffiliation
Prajwal Rajappa
Prajwal RajappaThe Ohio State University Wexner Medical Center
Prajwal RajappaThe Institute for Genomic Medicine, Nationwide Children's Hospital
Prajwal RajappaEnglander Institute of Precision Medicine
Kenneth EngEnglander Institute of Precision Medicine
Rohan BarejaEnglander Institute of Precision Medicine
Tuo ZhangEnglander Institute of Precision Medicine
Mark M Souweidane
Mark M Souweidane
Olivier ElementoEnglander Institute of Precision Medicine
Olivier ElementoEnglander Institute of Precision Medicine
Andrea SbonerEnglander Institute of Precision Medicine
Andrea SbonerEnglander Institute of Precision Medicine
Jeffrey P GreenfieldEnglander Institute of Precision Medicine
Jeffrey P GreenfieldEnglander Institute of Precision Medicine
Jeffrey P Greenfield
Jeffrey P Greenfield
David J PisapiaEnglander Institute of Precision Medicine
David J Pisapia
  • 1 - 19

Datasets

Release 1.2